Home
/ Indena
/ Competitors

Indena Competitors and Similar CompaniesClear all

Indena's competitors and similar companies include USV, Neptunus, Vectura Group and Unither Pharmaceuticals.

	Indena Indena is a company that specializes in the identification, development, and production of active principles derived from plants for the pharmaceutical and health-food industries.	USV USV is a pharmaceutical and biotechnology company.	Neptunus Neptunus is a biotechnology company that produces and distributes medicines.	Vectura Group Vectura Group is a product development company that focuses on drug delivery.	Unither Pharmaceuticals Unither Pharmaceuticals is a company that engages in sterile unit-doses contract manufacturing.
Founding Date	Founding Date 1921	Founding Date 1961	Founding Date 1989	Founding Date N/A	Founding Date 1993
Type	Type Subsidiary	Type Private	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech pharma platform	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Milan, IT HQ Paris, FR Chiyoda City, JP Seattle, US	Locations Mumbai, IN HQ	Locations Shen Zhen Shi, CN HQ	Locations Chippenham, GB HQ Saint Quentin Fallavier, FR Gauting, DE München, DE Muttenz, CH London, GB London, GB see more	Locations Amiens, FR HQ Wuhan Shi, CN Colomiers, FR Coutances, FR Gannat, FR see more
Employees	Employees 502	Employees 5,4971% increase	Employees 1,485	Employees 502	Employees 1,4801% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥972m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥653.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥330.8m (FY, 2025)	Gross profit £2.3m (FY, 2022)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income (¥53.1m) (FY, 2025)	Net income (£158m) (FY, 2022)	Net income N/A